Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: sds who wrote (1887)	4/6/1998 9:52:00 AM
From: Scott H. Davis	Respond to of 4676

Isis and CIBA Vision Present Positive Phase III Results For Antisense CMV Retinitis Drug (link follows) Scott biz.yahoo.com

To: sds who wrote (1887)	4/6/1998 9:59:00 AM
From: George R Janz	Respond to of 4676

Yes, I agree. It seems that their first round of commercial applications will not generate alot of cash - and that is a concern. Question being, when revenue generated falls short - where do the add'tl bucks come from. I too am long and also considering other options.